tiprankstipranks
Trending News
More News >
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market

TherapeuticsMD (TXMD) Financial Statements

Compare
2,247 Followers

TherapeuticsMD Financial Overview

TherapeuticsMD's market cap is currently $23.84M. The company's EPS TTM is $0.013; its P/E ratio is 78.93; TherapeuticsMD is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.76M$ 1.30M$ 69.96M$ 2.57M$ 64.87M
Gross Profit$ 1.76M$ 1.30M$ 68.57M$ 1.17M$ 48.90M
Operating Income$ -4.76M$ -8.52M$ 1.19M$ -79.58M$ -155.54M
EBITDA$ -2.98M$ -8.08M$ 11.86M$ -70.84M$ -153.41M
Net Income$ -2.18M$ -10.28M$ 112.00M$ -172.41M$ -183.52M
Balance Sheet
Cash & Short-Term Investments$ 5.06M$ 4.33M$ 38.07M$ 64.91M$ 80.49M
Total Assets$ 38.82M$ 43.31M$ 90.46M$ 169.47M$ 181.61M
Total Debt$ 7.17M$ 8.01M$ 8.76M$ 197.69M$ 248.63M
Net Debt$ 2.12M$ 3.68M$ -29.31M$ 132.79M$ 168.14M
Total Liabilities$ 11.45M$ 14.02M$ 55.31M$ 263.09M$ 305.61M
Stockholders' Equity$ 27.37M$ 29.29M$ 35.14M$ -93.62M$ -124.00M
Cash Flow
Free Cash Flow$ 732.00K$ 0.00$ -4.43M$ -147.84M$ -161.07M
Operating Cash Flow$ 732.00K$ -48.14M$ -4.08M$ -147.81M$ -159.47M
Investing Cash Flow$ 0.00$ 0.00$ 223.48M$ -2.22M$ -1.60M
Financing Cash Flow$ 0.00$ 3.15M$ -235.21M$ 134.67M$ 80.72M
Currency in USD

TherapeuticsMD Earnings and Revenue History

TherapeuticsMD Debt to Assets

TherapeuticsMD Cash Flow

TherapeuticsMD Forecast EPS vs Actual EPS